{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:13:03Z","timestamp":1792591983661,"version":"4.5.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The capacity to survive and thrive in conditions of limited resources and high inflammation is a major driver of tumor malignancy. Here we identified slow-cycling ADAM12\n                    <jats:sup>+<\/jats:sup>\n                    PDGFR\u03b1\n                    <jats:sup>+<\/jats:sup>\n                    mesenchymal stromal cells (MSCs) induced at the tumor margins in mouse models of melanoma, pancreatic cancer and prostate cancer. Using inducible lineage tracing and transcriptomics, we demonstrated that metabolically altered ADAM12\n                    <jats:sup>+<\/jats:sup>\n                    MSCs induced pathological angiogenesis and immunosuppression by promoting macrophage efferocytosis and polarization through overexpression of genes such as\n                    <jats:italic>Gas6<\/jats:italic>\n                    ,\n                    <jats:italic>Lgals3<\/jats:italic>\n                    and\n                    <jats:italic>Csf1<\/jats:italic>\n                    . Genetic depletion of ADAM12\n                    <jats:sup>+<\/jats:sup>\n                    cells restored a functional tumor vasculature, reduced hypoxia and acidosis and normalized CAFs, inducing infiltration of effector T cells and growth inhibition of melanomas and pancreatic neuroendocrine cancer, in a process dependent on TGF-\u03b2. In human cancer, ADAM12 stratifies patients with high levels of hypoxia and innate resistance mechanisms, as well as factors associated with a poor prognosis and drug resistance such as AXL. Altogether, our data show that depletion of tumor-induced slow-cycling PDGFR\u03b1\n                    <jats:sup>+<\/jats:sup>\n                    MSCs through ADAM12 restores antitumor immunity.\n                  <\/jats:p>","DOI":"10.1038\/s41590-023-01642-7","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T12:02:10Z","timestamp":1696507330000},"page":"1867-1878","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Depletion of slow-cycling PDGFR\u03b1+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis"],"prefix":"10.1038","volume":"24","author":[{"given":"Selene E.","family":"Di Carlo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Raffenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3980-4463","authenticated-orcid":false,"given":"Hugo","family":"Varet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anais","family":"Ode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Cabrerizo","family":"Granados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merle","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5196-9431","authenticated-orcid":false,"given":"Rachel","family":"Legendre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3691-275X","authenticated-orcid":false,"given":"Jan","family":"Tuckermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Bousquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2414-4407","authenticated-orcid":false,"given":"Lucie","family":"Peduto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"1642_CR1","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.trecan.2016.10.016","volume":"2","author":"L Schito","year":"2016","unstructured":"Schito, L. & Semenza, G. L. Hypoxia-inducible factors: master regulators of cancer progression. Trends Cancer 2, 758\u2013770 (2016).","journal-title":"Trends Cancer"},{"key":"1642_CR2","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1056\/NEJMra0910283","volume":"364","author":"HK Eltzschig","year":"2011","unstructured":"Eltzschig, H. K. & Carmeliet, P. Hypoxia and inflammation. N. Engl. J. Med. 364, 656\u2013665 (2011).","journal-title":"N. Engl. J. Med."},{"key":"1642_CR3","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1172\/JCI84433","volume":"126","author":"CT Taylor","year":"2016","unstructured":"Taylor, C. T., Doherty, G., Fallon, P. G. & Cummins, E. P. Hypoxia-dependent regulation of inflammatory pathways in immune cells. J. Clin. Invest. 126, 3716\u20133724 (2016).","journal-title":"J. Clin. Invest."},{"key":"1642_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.semcancer.2017.03.001","volume":"43","author":"V Huber","year":"2017","unstructured":"Huber, V. et al. Cancer acidity: an ultimate frontier of tumor immune escape and a novel target of immunomodulation. Semin. Cancer Biol. 43, 74\u201389 (2017).","journal-title":"Semin. Cancer Biol."},{"key":"1642_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.trecan.2018.10.010","volume":"5","author":"C Prunier","year":"2019","unstructured":"Prunier, C., Baker, D., Ten Dijke, P. & Ritsma, L. TGF-\u03b2 family signaling pathways in cellular dormancy. Trends Cancer 5, 66\u201378 (2019).","journal-title":"Trends Cancer"},{"key":"1642_CR6","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","volume":"50","author":"E Batlle","year":"2019","unstructured":"Batlle, E. & Massague, J. Transforming growth factor-\u03b2 signaling in immunity and cancer. Immunity 50, 924\u2013940 (2019).","journal-title":"Immunity"},{"key":"1642_CR7","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/ng.3398","volume":"47","author":"RA Moffitt","year":"2015","unstructured":"Moffitt, R. A. et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat. Genet. 47, 1168\u20131178 (2015).","journal-title":"Nat. Genet."},{"key":"1642_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nm.4082","volume":"22","author":"H Laklai","year":"2016","unstructured":"Laklai, H. et al. Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression. Nat. Med. 22, 497\u2013505 (2016).","journal-title":"Nat. Med."},{"key":"1642_CR9","doi-asserted-by":"publisher","first-page":"107628","DOI":"10.1016\/j.celrep.2020.107628","volume":"31","author":"S Davidson","year":"2020","unstructured":"Davidson, S. et al. Single-cell RNA sequencing reveals a dynamic stromal niche that supports tumor growth. Cell Rep. 31, 107628 (2020).","journal-title":"Cell Rep."},{"key":"1642_CR10","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1158\/2159-8290.CD-19-0644","volume":"10","author":"CX Dominguez","year":"2020","unstructured":"Dominguez, C. X. et al. Single-cell RNA sequencing reveals stromal evolution into LRRC15+ myofibroblasts as a determinant of patient response to cancer immunotherapy. Cancer Discov. 10, 232\u2013253 (2020).","journal-title":"Cancer Discov."},{"key":"1642_CR11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","volume":"33","author":"A Costa","year":"2018","unstructured":"Costa, A. et al. Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell 33, 463\u2013479 (2018).","journal-title":"Cancer Cell"},{"key":"1642_CR12","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1126\/science.1171362","volume":"324","author":"KP Olive","year":"2009","unstructured":"Olive, K. P. et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324, 1457\u20131461 (2009).","journal-title":"Science"},{"key":"1642_CR13","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1126\/science.1195300","volume":"330","author":"M Kraman","year":"2010","unstructured":"Kraman, M. et al. Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-\u03b1. Science 330, 827\u2013830 (2010).","journal-title":"Science"},{"key":"1642_CR14","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan, S. et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554, 544\u2013548 (2018).","journal-title":"Nature"},{"key":"1642_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","volume":"25","author":"AD Rhim","year":"2014","unstructured":"Rhim, A. D. et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell 25, 735\u2013747 (2014).","journal-title":"Cancer Cell"},{"key":"1642_CR16","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","volume":"25","author":"BC Ozdemir","year":"2014","unstructured":"Ozdemir, B. C. et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell 25, 719\u2013734 (2014).","journal-title":"Cancer Cell"},{"key":"1642_CR17","doi-asserted-by":"publisher","first-page":"E3091","DOI":"10.1073\/pnas.1411679111","volume":"111","author":"JJ Lee","year":"2014","unstructured":"Lee, J. J. et al. Stromal response to Hedgehog signaling restrains pancreatic cancer progression. Proc. Natl Acad. Sci. USA 111, E3091\u2013E3100 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1642_CR18","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.jaci.2017.12.998","volume":"142","author":"HW Cheng","year":"2018","unstructured":"Cheng, H. W. et al. CCL19-producing fibroblastic stromal cells restrain lung carcinoma growth by promoting local antitumor T-cell responses. J. Allergy Clin. Immunol. 142, 1257\u20131271 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1642_CR19","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.1172\/JCI136760","volume":"130","author":"H Jiang","year":"2020","unstructured":"Jiang, H. et al. Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix. J. Clin. Invest. 130, 4704\u20134709 (2020).","journal-title":"J. Clin. Invest."},{"key":"1642_CR20","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ccell.2021.02.007","volume":"39","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. Type I collagen deletion in \u03b1SMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer. Cancer Cell 39, 548\u2013565 (2021).","journal-title":"Cancer Cell"},{"key":"1642_CR21","doi-asserted-by":"publisher","first-page":"e146987","DOI":"10.1172\/JCI146987","volume":"131","author":"S Bhattacharjee","year":"2021","unstructured":"Bhattacharjee, S. et al. Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts. J. Clin. Invest. 131, e146987 (2021).","journal-title":"J. Clin. Invest."},{"key":"1642_CR22","doi-asserted-by":"publisher","first-page":"5462","DOI":"10.1038\/sj.onc.1209536","volume":"25","author":"L Peduto","year":"2006","unstructured":"Peduto, L. et al. ADAM12 is highly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progression. Oncogene 25, 5462\u20135466 (2006).","journal-title":"Oncogene"},{"key":"1642_CR23","doi-asserted-by":"publisher","first-page":"7359","DOI":"10.1158\/1078-0432.CCR-06-1066","volume":"12","author":"C Frohlich","year":"2006","unstructured":"Frohlich, C. et al. Molecular profiling of ADAM12 in human bladder cancer. Clin. Cancer Res. 12, 7359\u20137368 (2006).","journal-title":"Clin. Cancer Res."},{"key":"1642_CR24","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1053\/jhep.2003.50205","volume":"37","author":"H Le Pabic","year":"2003","unstructured":"Le Pabic, H. et al. ADAM12 in human liver cancers: TGF-\u03b2-regulated expression in stellate cells is associated with matrix remodeling. Hepatology 37, 1056\u20131066 (2003).","journal-title":"Hepatology"},{"key":"1642_CR25","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s12253-013-9639-8","volume":"19","author":"N Cireap","year":"2013","unstructured":"Cireap, N. & Narita, D. Molecular profiling of ADAM12 and ADAM17 genes in human malignant melanoma. Pathol. Oncol. Res. 19, 755\u2013762 (2013).","journal-title":"Pathol. Oncol. Res."},{"key":"1642_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-018-0096-9","volume":"7","author":"VL Veenstra","year":"2018","unstructured":"Veenstra, V. L. et al. ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy. Oncogenesis 7, 87 (2018).","journal-title":"Oncogenesis"},{"key":"1642_CR27","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/nm.2848","volume":"18","author":"S Dulauroy","year":"2012","unstructured":"Dulauroy, S., Di Carlo, S. E., Langa, F., Eberl, G. & Peduto, L. Lineage tracing and genetic ablation of ADAM12+ perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nat. Med. 18, 1262\u20131270 (2012).","journal-title":"Nat. Med."},{"key":"1642_CR28","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s10549-011-1431-4","volume":"131","author":"R Roy","year":"2012","unstructured":"Roy, R. & Moses, M. A. ADAM12 induces estrogen-independence in breast cancer cells. Breast Cancer Res. Treat. 131, 731\u2013741 (2012).","journal-title":"Breast Cancer Res. Treat."},{"key":"1642_CR29","first-page":"13279","volume":"8","author":"B Ma","year":"2015","unstructured":"Ma, B. et al. ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer. Int. J. Clin. Exp. Pathol. 8, 13279\u201313283 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"1642_CR30","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1093\/carcin\/bgv059","volume":"36","author":"DJ Cheon","year":"2015","unstructured":"Cheon, D. J. et al. ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma. Carcinogenesis 36, 739\u2013747 (2015).","journal-title":"Carcinogenesis"},{"key":"1642_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10608-y","volume":"12","author":"S Du","year":"2022","unstructured":"Du, S. et al. ADAM12 is an independent predictor of poor prognosis in liver cancer. Sci. Rep. 12, 6634 (2022).","journal-title":"Sci. Rep."},{"key":"1642_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09436-0","volume":"22","author":"S Ten Hoorn","year":"2022","unstructured":"Ten Hoorn, S. et al. Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer. BMC Cancer 22, 394 (2022).","journal-title":"BMC Cancer"},{"key":"1642_CR33","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/jso.21313","volume":"100","author":"N Mino","year":"2009","unstructured":"Mino, N. et al. A disintegrin and metalloprotease 12 (ADAM12) is a prognostic factor in resected pathological stage I lung adenocarcinoma. J. Surg. Oncol. 100, 267\u2013272 (2009).","journal-title":"J. Surg. Oncol."},{"key":"1642_CR34","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nri3902","volume":"15","author":"SJ Turley","year":"2015","unstructured":"Turley, S. J., Cremasco, V. & Astarita, J. L. Immunological hallmarks of stromal cells in the tumour microenvironment. Nat. Rev. Immunol. 15, 669\u2013682 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"1642_CR35","doi-asserted-by":"publisher","first-page":"E1147","DOI":"10.1073\/pnas.1717802115","volume":"115","author":"M Djurec","year":"2018","unstructured":"Djurec, M. et al. Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors. Proc. Natl Acad. Sci. USA 115, E1147\u2013E1156 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1642_CR36","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1158\/0008-5472.CAN-16-1986","volume":"77","author":"SB Gomez-Chou","year":"2017","unstructured":"Gomez-Chou, S. B. et al. Lipocalin-2 promotes pancreatic ductal adenocarcinoma by regulating inflammation in the tumor microenvironment. Cancer Res. 77, 2647\u20132660 (2017).","journal-title":"Cancer Res."},{"key":"1642_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/srep07235","volume":"4","author":"I Nakamura","year":"2014","unstructured":"Nakamura, I. et al. Lipocalin2 as a plasma marker for tumors with hypoxic regions. Sci. Rep. 4, 7235 (2014).","journal-title":"Sci. Rep."},{"key":"1642_CR38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-3-030-40146-7_5","volume":"1245","author":"G Gonzalez-Avila","year":"2020","unstructured":"Gonzalez-Avila, G., Sommer, B., Garcia-Hernandez, A. A. & Ramos, C. Matrix metalloproteinases\u2019 role in tumor microenvironment. Adv. Exp. Med. Biol. 1245, 97\u2013131 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"key":"1642_CR39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","volume":"38","author":"S Pastorekova","year":"2019","unstructured":"Pastorekova, S. & Gillies, R. J. The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond. Cancer Metastasis Rev. 38, 65\u201377 (2019).","journal-title":"Cancer Metastasis Rev."},{"key":"1642_CR40","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1158\/0008-5472.CAN-11-1272","volume":"72","author":"A Calcinotto","year":"2012","unstructured":"Calcinotto, A. et al. Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes. Cancer Res. 72, 2746\u20132756 (2012).","journal-title":"Cancer Res."},{"key":"1642_CR41","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1158\/0008-5472.CAN-15-1743","volume":"76","author":"S Pilon-Thomas","year":"2016","unstructured":"Pilon-Thomas, S. et al. Neutralization of tumor acidity improves antitumor responses to immunotherapy. Cancer Res. 76, 1381\u20131390 (2016).","journal-title":"Cancer Res."},{"key":"1642_CR42","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nrd3455","volume":"10","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet, P. & Jain, R. K. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat. Rev. Drug Discov. 10, 417\u2013427 (2011).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1642_CR43","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1182\/blood-2004-04-1485","volume":"104","author":"M Uutela","year":"2004","unstructured":"Uutela, M. et al. PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis. Blood 104, 3198\u20133204 (2004).","journal-title":"Blood"},{"key":"1642_CR44","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.canlet.2015.10.036","volume":"380","author":"L Ye","year":"2016","unstructured":"Ye, L. & Jiang, W. G. Bone morphogenetic proteins in tumour associated angiogenesis and implication in cancer therapies. Cancer Lett. 380, 586\u2013597 (2016).","journal-title":"Cancer Lett."},{"key":"1642_CR45","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1158\/0008-5472.CAN-22-2316","volume":"83","author":"S Schwoerer","year":"2023","unstructured":"Schwoerer, S. et al. Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines. Cancer Res. 83, 1596\u20131610 (2023).","journal-title":"Cancer Res."},{"key":"1642_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-022-00434-2","volume":"11","author":"AM Mello","year":"2022","unstructured":"Mello, A. M. et al. Hypoxia promotes an inflammatory phenotype of fibroblasts in pancreatic cancer. Oncogenesis 11, 56 (2022).","journal-title":"Oncogenesis"},{"key":"1642_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1022-2","volume":"18","author":"KV Myers","year":"2019","unstructured":"Myers, K. V., Amend, S. R. & Pienta, K. J. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment. Mol. Cancer 18, 94 (2019).","journal-title":"Mol. Cancer"},{"key":"1642_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10968-6","volume":"10","author":"C Vennin","year":"2019","unstructured":"Vennin, C. et al. CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan. Nat. Commun. 10, 3637 (2019).","journal-title":"Nat. Commun."},{"key":"1642_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16199-4","volume":"11","author":"O Saatci","year":"2020","unstructured":"Saatci, O. et al. Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer. Nat. Commun. 11, 2416 (2020).","journal-title":"Nat. Commun."},{"key":"1642_CR50","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.trecan.2020.12.001","volume":"7","author":"YW Shen","year":"2021","unstructured":"Shen, Y. W., Zhou, Y. D., Chen, H. Z., Luan, X. & Zhang, W. D. Targeting CTGF in cancer: an emerging therapeutic opportunity. Trends Cancer 7, 511\u2013524 (2021).","journal-title":"Trends Cancer"},{"key":"1642_CR51","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41586-022-05272-1","volume":"611","author":"AT Krishnamurty","year":"2022","unstructured":"Krishnamurty, A. T. et al. LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity. Nature 611, 148\u2013154 (2022).","journal-title":"Nature"},{"key":"1642_CR52","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nrc1208","volume":"3","author":"PM Siegel","year":"2003","unstructured":"Siegel, P. M. & Massague, J. Cytostatic and apoptotic actions of TGF-\u03b2 in homeostasis and cancer. Nat. Rev. Cancer 3, 807\u2013821 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"1642_CR53","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1161\/ATVBAHA.107.161521","volume":"29","author":"K Gaengel","year":"2009","unstructured":"Gaengel, K., Genove, G., Armulik, A. & Betsholtz, C. Endothelial\u2013mural cell signaling in vascular development and angiogenesis. Arterioscler. Thromb. Vasc. Biol. 29, 630\u2013638 (2009).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1642_CR54","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.immuni.2019.04.018","volume":"50","author":"S Morioka","year":"2019","unstructured":"Morioka, S., Maueroder, C. & Ravichandran, K. S. Living on the edge: efferocytosis at the interface of homeostasis and pathology. Immunity 50, 1149\u20131162 (2019).","journal-title":"Immunity"},{"key":"1642_CR55","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani, A., Marchesi, F., Malesci, A., Laghi, L. & Allavena, P. Tumour-associated macrophages as treatment targets in oncology. Nat. Rev. Clin. Oncol. 14, 399\u2013416 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1642_CR56","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00281-018-0698-5","volume":"40","author":"TA Werfel","year":"2018","unstructured":"Werfel, T. A. & Cook, R. S. Efferocytosis in the tumor microenvironment. Semin Immunopathol 40, 545\u2013554 (2018).","journal-title":"Semin Immunopathol"},{"key":"1642_CR57","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1182\/blood-2005-08-3485","volume":"107","author":"Z Fan","year":"2006","unstructured":"Fan, Z. et al. NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors. Blood 107, 1342\u20131351 (2006).","journal-title":"Blood"},{"key":"1642_CR58","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1016\/j.celrep.2015.12.004","volume":"13","author":"A Johansson-Percival","year":"2015","unstructured":"Johansson-Percival, A. et al. Intratumoral LIGHT restores pericyte contractile properties and vessel integrity. Cell Rep. 13, 2687\u20132698 (2015).","journal-title":"Cell Rep."},{"key":"1642_CR59","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/ni.2986","volume":"15","author":"A Zagorska","year":"2014","unstructured":"Zagorska, A., Traves, P. G., Lew, E. D., Dransfield, I. & Lemke, G. Diversification of TAM receptor tyrosine kinase function. Nat. Immunol. 15, 920\u2013928 (2014).","journal-title":"Nat. Immunol."},{"key":"1642_CR60","doi-asserted-by":"publisher","first-page":"eaak9670","DOI":"10.1126\/scitranslmed.aak9670","volume":"9","author":"M Schmittnaegel","year":"2017","unstructured":"Schmittnaegel, M. et al. Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade. Sci. Transl. Med. 9, eaak9670 (2017).","journal-title":"Sci. Transl. Med."},{"key":"1642_CR61","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","volume":"21","author":"A Armulik","year":"2011","unstructured":"Armulik, A., Genove, G. & Betsholtz, C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell 21, 193\u2013215 (2011).","journal-title":"Dev. Cell"},{"key":"1642_CR62","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jhep.2005.05.025","volume":"43","author":"H Le Pabic","year":"2005","unstructured":"Le Pabic, H. et al. Involvement of the serine\/threonine p70S6 kinase in TGF-\u03b21-induced ADAM12 expression in cultured human hepatic stellate cells. J. Hepatol. 43, 1038\u20131044 (2005).","journal-title":"J. Hepatol."},{"key":"1642_CR63","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/cam4.160","volume":"3","author":"BS Misemer","year":"2014","unstructured":"Misemer, B. S. et al. Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activity. Cancer Med. 3, 81\u201390 (2014).","journal-title":"Cancer Med."},{"key":"1642_CR64","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1073\/pnas.1820459116","volume":"116","author":"EA Ebbing","year":"2019","unstructured":"Ebbing, E. A. et al. Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma. Proc. Natl Acad. Sci. USA 116, 2237\u20132242 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1642_CR65","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2018.08.033","volume":"155","author":"F Puleo","year":"2018","unstructured":"Puleo, F. et al. Stratification of pancreatic ductal adenocarcinomas based on tumor and microenvironment features. Gastroenterology 155, 1999\u20132013 e1993 (2018).","journal-title":"Gastroenterology"},{"key":"1642_CR66","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","volume":"18","author":"SA Jones","year":"2018","unstructured":"Jones, S. A. & Jenkins, B. J. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer. Nat. Rev. Immunol. 18, 773\u2013789 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"1642_CR67","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrc1819","volume":"6","author":"M Cully","year":"2006","unstructured":"Cully, M., You, H., Levine, A. J. & Mak, T. W. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat. Rev. Cancer 6, 184\u2013192 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"1642_CR68","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccr.2009.12.041","volume":"17","author":"N Erez","year":"2010","unstructured":"Erez, N., Truitt, M., Olson, P., Arron, S. T. & Hanahan, D. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-\u03baB-dependent manner. Cancer Cell 17, 135\u2013147 (2010).","journal-title":"Cancer Cell"},{"key":"1642_CR69","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/nature08486","volume":"461","author":"AJ Trimboli","year":"2009","unstructured":"Trimboli, A. J. et al. Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 461, 1084\u20131091 (2009).","journal-title":"Nature"},{"key":"1642_CR70","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ccell.2016.05.017","volume":"30","author":"CE Lewis","year":"2016","unstructured":"Lewis, C. E., Harney, A. S. & Pollard, J. W. The multifaceted role of perivascular macrophages in tumors. Cancer Cell 30, 18\u201325 (2016).","journal-title":"Cancer Cell"},{"key":"1642_CR71","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.cell.2016.07.032","volume":"166","author":"D Clever","year":"2016","unstructured":"Clever, D. et al. Oxygen sensing by T cells establishes an immunologically tolerant metastatic niche. Cell 166, 1117\u20131131 (2016).","journal-title":"Cell"},{"key":"1642_CR72","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrc.2017.77","volume":"17","author":"C Corbet","year":"2017","unstructured":"Corbet, C. & Feron, O. Tumour acidosis: from the passenger to the driver\u2019s seat. Nat. Rev. Cancer 17, 577\u2013593 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"1642_CR73","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1172\/JCI84430","volume":"126","author":"D Triner","year":"2016","unstructured":"Triner, D. & Shah, Y. M. Hypoxia-inducible factors: a central link between inflammation and cancer. J. Clin. Invest. 126, 3689\u20133698 (2016).","journal-title":"J. Clin. Invest."},{"key":"1642_CR74","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1093\/nar\/gnf134","volume":"30","author":"K Schonig","year":"2002","unstructured":"Schonig, K., Schwenk, F., Rajewsky, K. & Bujard, H. Stringent doxycycline dependent control of CRE recombinase in vivo. Nucleic Acids Res. 30, e134 (2002).","journal-title":"Nucleic Acids Res."},{"key":"1642_CR75","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1182\/blood.V100.2.560","volume":"100","author":"P Leveen","year":"2002","unstructured":"Leveen, P. et al. Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable. Blood. 100, 560\u2013568 (2002).","journal-title":"Blood."},{"key":"1642_CR76","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1084\/jem.183.1.283","volume":"183","author":"CM Celluzzi","year":"1996","unstructured":"Celluzzi, C. M., Mayordomo, J. I., Storkus, W. J., Lotze, M. T. & Falo, L. D. Jr. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J. Exp. Med. 183, 283\u2013287 (1996).","journal-title":"J. Exp. Med."},{"key":"1642_CR77","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1073\/pnas.92.8.3439","volume":"92","author":"NM Greenberg","year":"1995","unstructured":"Greenberg, N. M. et al. Prostate cancer in a transgenic mouse. Proc. Natl Acad. Sci. USA 92, 3439\u20133443 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1642_CR78","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/315115a0","volume":"315","author":"D Hanahan","year":"1985","unstructured":"Hanahan, D. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin\/simian virus 40 oncogenes. Nature 315, 115\u2013122 (1985).","journal-title":"Nature"},{"key":"1642_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01982-3","volume":"17","author":"JC DuBois","year":"2020","unstructured":"DuBois, J. C., Ray, A. K., Davies, P. & Shafit-Zagardo, B. Anti-Axl antibody treatment reduces the severity of experimental autoimmune encephalomyelitis. J. Neuroinflammation 17, 324 (2020).","journal-title":"J. Neuroinflammation"},{"key":"1642_CR80","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1093\/bioinformatics\/bts480","volume":"28","author":"J Koster","year":"2012","unstructured":"Koster, J. & Rahmann, S. Snakemake\u2014a scalable bioinformatics workflow engine. Bioinformatics 28, 2520\u20132522 (2012).","journal-title":"Bioinformatics"},{"key":"1642_CR81","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels, P., Magnusson, M., Lundin, S. & Kaller, M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32, 3047\u20133048 (2016).","journal-title":"Bioinformatics"},{"key":"1642_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"1642_CR83","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey, P. et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531, 47\u201352 (2016).","journal-title":"Nature"},{"key":"1642_CR84","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1016\/j.cell.2021.08.003","volume":"184","author":"K Pelka","year":"2021","unstructured":"Pelka, K. et al. Spatially organized multicellular immune hubs in human colorectal cancer. Cell 184, 4734\u20134752 (2021).","journal-title":"Cell"},{"key":"1642_CR85","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","volume":"175","author":"L Jerby-Arnon","year":"2018","unstructured":"Jerby-Arnon, L. et al. A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade. Cell 175, 984\u2013997 (2018).","journal-title":"Cell"},{"key":"1642_CR86","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41422-019-0195-y","volume":"29","author":"J Peng","year":"2019","unstructured":"Peng, J. et al. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Cell Res. 29, 725\u2013738 (2019).","journal-title":"Cell Res."},{"key":"1642_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht, E. et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 17, 218 (2016).","journal-title":"Genome Biol."},{"key":"1642_CR88","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-1-4939-2929-0_6","volume":"1339","author":"I Pineda-Torra","year":"2015","unstructured":"Pineda-Torra, I., Gage, M., de Juan, A. & Pello, O. M. Isolation, culture, and polarization of murine bone marrow-derived and peritoneal macrophages. Methods Mol. Biol. 1339, 101\u2013109 (2015).","journal-title":"Methods Mol. Biol."},{"key":"1642_CR89","doi-asserted-by":"publisher","first-page":"e12414","DOI":"10.7554\/eLife.12414","volume":"5","author":"ET Schmid","year":"2016","unstructured":"Schmid, E. T. et al. AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity. eLife 5, e12414 (2016).","journal-title":"eLife"},{"key":"1642_CR90","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1023\/A:1008942828960","volume":"8","author":"BE Clausen","year":"1999","unstructured":"Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R. & Forster, I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8, 265\u2013277 (1999).","journal-title":"Transgenic Res."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01642-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01642-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01642-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T10:06:01Z","timestamp":1698314761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01642-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":90,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1642"],"URL":"https:\/\/doi.org\/10.1038\/s41590-023-01642-7","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,5]]},"assertion":[{"value":"16 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}